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Abstract.
Background/Objectives: Visuospatial problems are common in Parkinson’s disease (PD) and likely stem from dysfunction in
dopaminergic pathways and consequent disruption of cortical functioning. Characterizing the motor symptoms at disease onset
provides a method of observing how dysfunction in these pathways influences visuospatial cognition. We examined two types
of motor characteristics: Body side (left or right) and type of initial symptom (tremor or symptom other than tremor).
Methods: 31 non-demented patients with PD, 16 with left-side onset (LPD) and 15 with right-side onset (RPD), as well as 17
healthy control participants (HC). The PD group was also divided by type of initial motor symptom, 15 having tremor as the
initial symptom and 16 having an initial symptom other than tremor. Visuospatial function was assessed with the Clock Drawing
Test.
Results: Of the four Clock Drawing scoring methods used, the Rouleau method showed sensitivity to subgroup differences. As
predicted, the LPD and non-tremor subgroups, but not the other subgroups, performed more poorly than the HC group.
Conclusion: The findings provide further evidence for differences in cognition between these subtypes of PD and highlight the
importance of considering disease subtypes when examining cognition.
Keywords: Functional laterality, parkinsonian, spatial behavior, cognition, neuropsychology
Visuospatial problems are frequently reported by
patients with Parkinson’s disease (PD) [1] and sig-
nificantly interfere with quality of life [2–4]. These
symptoms likely originate from depletion of dopamine
(DA) in the substantia nigra (SN) and the consequent
disruption of neural circuits including those with nodes
in the prefrontal and posterior parietal cortices [5–6].
Recent studies have supported earlier work indicat-
ing that several aspects of visuospatial functioning are
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impaired in PD, including deficits in spatial navigation
[7], mental rotation [8], hierarchical pattern percep-
tion [9], facial emotion recognition [10], visuospatial
working memory [11, 12], and visuospatial planning
[13]. Not all PD patients show impairments to the same
degree, consistent with views that PD may encompass
multiple subtypes [14].
Disruption of dopaminergic pathways from the mid-
brain to basal ganglia and cortical areas results in par-
ticular cognitive consequences, which may explain the
heterogeneity of cognitive dysfunction in PD. Clinical
characteristics at disease onset, such as side of motor
symptom onset (left or right) or type of initial motor
symptom (tremor or akinesia/rigidity/posture/gait),
may suggest a method for observing how dysfunction
in these pathways influences cognition. For example,
ISSN 1877-7171/15/$35.00 © 2015 – IOS Press and the authors. All rights reserved
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dysfunction in pathways predominantly affecting the
right hemisphere impairs performance on visuospatial
tasks, especially those requiring processing the over-
all figure rather than individual target features [7, 9].
PD patients typically present with a dominant type of
motor symptom (e.g., tremor or rigidity) that primarily
affects one side of the body, as described in Parkinson’s
original essay [15]. As the disease progresses, symp-
toms appear on the initially non-affected side, but the
initial side often remains more affected throughout the
disease course [16].
Regarding laterality, side of motor symptom onset
is associated with asymmetric DA depletion in the SN
[17], as well as asymmetric up-regulation of postsy-
naptic striatal D2 receptors [18, 19]. These asymmetric
changes in DA and its regulation result in asymmetric
effects on cortical areas [5, 6]. Visuospatial perfor-
mance may be especially affected either by disruption
of connections between the SN and the parietal lobes
[20] or indirectly as a downstream consequence of
frontal dysfunction [21, 22]. Multiple reports examin-
ing visuospatial functioning by side of motor symptom
onset have suggested that visuospatial problems in
PD result from disruptions in networks including the
parietal lobes [7, 9, 23]. Schendan and colleagues [9]
investigated the relation between motor symptom onset
and performance on a visuospatial task that was sen-
sitive to posterior parietal lobe functioning but not to
dorsolateral prefrontal cortex functioning (hierarchi-
cal pattern perception) and found dissociations in task
performance as a function of side of motor symp-
tom onset. These findings indicate that PD patients
with motor symptoms starting on the left side of the
body (LPD; predominant right hemisphere dysfunc-
tion) are at greater risk for visuospatial problems than
patients with symptoms starting on the right side of
the body (RPD; predominant left hemisphere dysfunc-
tion), likely reflecting in LPD the greater loss of DA
and changes in DA regulation in the right SN and basal
ganglia and their effects on the right posterior parietal
lobe.
The types of initial and dominant motor symptoms
are also associated with asymmetric DA depletion
within midbrain structures and, through connections
with the cortex, may have differing impacts on cogni-
tion and quality of life [24]. Single-photon emission
computed tomography (SPECT) studies consistently
report negative correlations between DA uptake in the
striatum and indicators of each of the cardinal symp-
toms of PD: Rigidity, bradykinesia, and disorders of
gait, balance and posture [17, 25, 26], with the excep-
tion of tremor, suggesting that tremor dominant and
non-tremor dominant PD result from dysfunction of
different neural systems. These findings have been
supported by a SPECT study [27] indicating greater
presynaptic DA binding in tremor-dominant PD than
in non-tremor dominant PD, despite similar disease
stage (Hoehn and Yahr stage I: Unilateral symptoms).
Perhaps even more compelling, a post-mortem study
[28] used high performance liquid chromatography
with electrochemical detection to determine DA con-
centrations within subregions of the globus pallidus
in PD patients and a control group. Specific differ-
ences in DA levels were found within subregions of
the internal globus pallidus between tremor-dominant
and non-tremor dominant patients. The non-tremor PD
group (n = 6) had DA loss within the dorsal rostral
( 80%) and ventral rostral ( 71%) subdivisions of this
region. By contrast, DA loss was observed only in the
dorsal rostral region in the tremor-dominant PD par-
ticipants (n = 2) and to a lesser degree ( 45%). The
results with this small sample suggest that the ven-
tral region of the internal globus pallidus plays a role
in non-tremor dominant but not in tremor-dominant
PD.
It is unknown how these biochemical differences
by initial symptom relate to cognition. Cross-sectional
[29–31] and community-based longitudinal studies
[32–34] indicate that non-tremor dominant PD is asso-
ciated with greater prevalence and incidence of overall
cognitive impairments, likely stemming from greater
posterior dysfunction as indicated by performance
on neuropsychological tests. For example, Williams-
Gray and colleagues [34] reported that the increased
risk of developing dementia in non-tremor PD (4.1
times greater) is further increased (to 5.3 times) in
non-tremor patients with baseline problems copy-
ing intersecting pentagons, a visuospatial task. These
reports have been limited in scope, however, focusing
primarily on overall cognition as measured by ver-
sions of the Mini-Mental State Examination and the
scales for outcomes in PD (SCOPA-COG). Whereas
multiple reports relate global cognitive decline to
type of motor symptom, the cognitive profile of early
stage non-demented patients with respect to present-
ing symptom is largely unknown. One report [35]
indicated greater executive dysfunction in PD patients
without tremor as the initial symptom, as assessed
by the Wisconsin Card Sorting Test. Executive dys-
function in this PD subgroup implicates prefrontal
impairment, consistent with observations of abnor-
mal synchronous oscillations in the basal ganglia that
provide “noisy” input to the frontal lobes, in turn
leading to akinesia and rigidity but not tremor [36].
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This study [35] also reported an interaction between
side and type of initial symptom on visuospatial func-
tioning, with right-onset tremor patients performing
better than left-onset tremor patients on the Hooper
Visual Organization Test and Judgment of Line Ori-
entation. Overall, the combination of biochemical,
epidemiological and neuropsychological studies sug-
gest that the type of initial and dominant motor
symptom may characterize subgroups of PD asso-
ciated with dysfunction of different neural circuits.
Patients with tremor as the initial motor symptom may
be at less risk of developing cognitive impairment
than patients with an initial motor symptom other than
tremor.
The present study examined cognitive performance
in non-demented patients with PD divided into sub-
groups by side of onset and initial motor symptom.
Because many visuospatial tests are able to distinguish
side-of-onset subgroups (as reviewed by Cronin-
Golomb [37]) and because visuospatial dysfunction
appears to predict overall cognitive difficulties in non-
tremor onset PD [34] we focused on this domain of
cognitive functioning. We used the Clock Drawing Test
(CDT), a standard neuropsychological measure sensi-
tive to visuospatial impairment and frequently used in
clinical settings [38].
Our primary goal was to examine the potential effect
of side and type of initial motor symptom on CDT per-
formance. Based on the current literature, we expected
LPD participants to perform more poorly than RPD and
healthy control participants, as the spatial demands of
the task would not be met by the dysfunctional right
hemisphere. Similarly, we expected PD patients with
an initial cardinal symptom other than tremor to per-
form poorly relative to PD patients first presenting
with tremor and relative to healthy control partici-
pants, reflecting reported differences in the relation
between dopamine and type of initial motor symp-
tom as well as greater cognitive dysfunction in this
subtype.
A secondary goal was to determine the sensitivity
of various CDT scoring systems to subtle cognitive
dysfunction in PD. Four scoring systems were selected
from more than a dozen reported in the literature. The
Sunderland method [39] was chosen for its frequency
of use. The Clock Drawing Interpretation Scale (CDIS)
[40] and the Rouleau method [41] were chosen for
the capacity to identify problems within each of the
three main features of the clock drawing (clock face,
numbers and hands). Finally, the Ten Point Clock Test
(TPCT) [42] was selected for its ease of use in clinical
settings.
METHODS
Participants
Participants included 31 patients with idiopathic PD
and 17 healthy control adults (HC), all right-handed.
PD patients were recruited from the Parkinson’s Dis-
ease Clinic at the Boston Medical Center and local
support groups. HC participants were recruited from
the community.
Exclusion criteria for both groups included co-
existing serious chronic medical illnesses (including
psychiatric or neurological), history of intracranial
surgery, traumatic brain injury, alcoholism or other
drug abuse, or eye disease or abnormalities, as well
as use of psychoactive medications besides antide-
pressants and anxiolytics in the PD group and use
of any psychoactive medications in the HC group.
Most participants (24/31 PD and 13/17 HC) under-
went a neuro-ophthalmological examination to rule out
ocular disorders. There were no differences in basic
visual functioning between those who did and did not
receive this examination (e.g., letter-identification con-
trast sensitivity, t(6.47) = 0.07, p = 0.54).
Review of PD participants’ medical records con-
firmed side of disease onset and disease duration. PD
participants were asked to provide a detailed descrip-
tion of their initial and current dominant symptom.
Patients who indicated the presence of tremor at onset
were categorized as tremor-onset. All other were con-
sidered non-tremor onset. “Non-tremor” is described
elsewhere as the akinesia/ rigidity subtype or the postu-
ral instability/ gait difficulty subtype [36]. The majority
of patients reported using dopamine agonists (26)
and/or levodopa (24). Seven used monoamine oxi-
dase inhibitors and/or catechol-O-methyltransferase
inhibitors (2 MAOI alone, 2 COMT alone, 2 both), 6
used amantadine, and 11 used anticholinergic agents.
Thirteen reported using antidepressant or anti-anxiety
medication. All participants were tested in the “on”
state with dosage optimized by their physician.
Side of onset. The HC, LPD (n = 16), and RPD
groups (n = 15) were matched for age (F (2, 47) = 0.43,
MSE = 30.52, p = 0.66), education (F (2, 47) = 0.27,
MSE = 1.99, p = 0.77), and male:female ratio. None
were demented, with all obtaining scores of 27 or
above on the Mini-Mental State Examination (MMSE)
and 139 or above on the Dementia Rating Scale
(DRS). LPD and RPD patients endorsed more depres-
sive symptoms than did HC on the Beck Depression
Inventory II (BDI-II) (F (2, 44) = 10.22, MSE = 290.73,
p < 0.01), with no difference between LPD and RPD
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(t (26) = 0.59, p = 0.56). The PD subgroups had sim-
ilar mild bilateral motor symptoms (as indicated
by a median stage II Hoehn and Yahr score [43];
Mann-Whitney U = 94, p = 0.14) and similar duration
of illness (t (29) = 1.5, p = 0.14). Use of DA ago-
nists was similar between groups with 13/16 LPD
and 13/15 RPD participants on these medications
(X2 [1, n = 31] = 0.17, p = 0.68). Likewise, use of
levodopa was similar between groups with 13/16
LPD and 11/15 RPD participants on these medi-
cations (X2 [1, n = 31] = 0.28, p = 0.60). Three LPD
and 3 RPD participants were on amantadine (X2
[1, n = 31] = 0.01, p = 0.93). Seven LPD and 4 RPD
participants were on anticholinergic agents (X2 [1,
n = 31] = 0.98, p = 0.32).
Type of initial symptom. The HC, PD tremor (n = 15)
and non-tremor (n = 16) groups did not differ on age
(F (2, 47) = 0.17, MSE = 12.25, p = 0.85), education (F
(2, 47) = 0.28, MSE = 2.06, p = 0.76), overall cognitive
status as indicated by the MMSE (F (2, 47) = 0.10,
MSE = 0.098, p = 0.91) and DRS (F (2, 42) = 1.70,
MSE = 2.53, p = 0.20), or male:female ratio. Tremor
and non-tremor patients endorsed more depressive
symptoms on the BDI-II than did HC participants (F
(2, 44) = 9.92, MSE = 285.03, p < 0.01), with no dif-
ference between the PD subgroups (t (19.0) = 0.30,
p = 0.77). Severity of motor symptoms was similar
in the subgroups with a median of stage II Hoehn
and Yahr (Mann-Whitney U = 104.5, p = 0.37). The
duration of illness did not differ between subgroups
(t (29) = 0.63, p = 0.53). Use of DA agonists was sim-
ilar between groups with 14/15 tremor and 12/16
non-tremor participants on these medications (X2
[1, n = 31] = 1.9, p = 0.17). Likewise, use of levodopa
was similar between groups with 13/15 tremor and
11/16 non-tremor participants on these medications
(X2 [1, n = 31] = 0.23, p = 0.23). Three tremor and 3
non-tremor participants were on amantadine (X2 [1,
n = 31] = 0.01, p = 0.93). Six tremor and 5 non-tremor
participants were on anticholinergic agents (X2 [1,
n = 31] = 1.17, p = 0.28).
Side of onset and type of initial symptom. In the
LPD subgroup, there were nine patients with and seven
without tremor as the initial symptom. In the RPD sub-
group, there were six patients with and nine without
tremor as the initial symptom (Table 1).
Measures and procedure
Participants provided informed consent for the pro-
tocol approved by the Boston University Charles River
Campus Institutional Review Board. The research
was conducted in accordance with the Helsinki
Declaration.
Each participant was provided a blank 8.5 × 11”
piece of white paper and the following instructions:
“I would like you to draw a clock including the num-
bers and set the hands to 10 after 11.” Clocks were
analyzed according to the following methods.
The Sunderland method [39] is a categorical rank-
ing system in which drawings are assigned to one of
ten previously identified clock representations. A “10”
represents a well-drawn clock and “1” indicates a
non-interpretable drawing. The 1–5 range primarily
reflects the accuracy of the clock numbers and face.
The 6–10 range reflects the placement of the hands,
with the clock face (outer contour) and numbers gen-
erally intact. Hands placed at 11:10 were considered
in the correct position.
The Clock Drawing Interpretation Scale (CDIS)
[40] consists of 20 items that indicate the presence or
absence of commonly observed errors. Inter-item cor-
Table 1
Participant characteristics
HC (n = 17) PD (n = 31)∗
Side of onset Type of initial symptom
LPD (n = 16) RPD (n = 15) T (n = 15) NT (n = 16)
Age (yrs) 61.5 (9.0) 60.0 (8.6) 62.8 (7.8) 62.3 (8.1) 60.5 (8.5)
Female: Male 9:6 9:7 9:6 8:7 9:7
Education (yrs) 16.4 (2.7) 16.6 (2.6) 17.0 (2.9) 16.6 (2.4) 17.0 (3.0)
Hoehn&Yahr N/A 2.0 (2-3) 2.0 (2-4) 2.0 (2-3) 2.0 (2-4)
Duration of illness (yrs) N/A 6.8 (3.6) 4.9 (3.1) 5.5 (2.7) 6.3 (4.0)
MMSE 29.4 (0.9) 29.4 (1.1) 29.1 (1.0) 29.2 (1.1) 29.3 (1.1)
DRS 143.5 (1.1) 142.6 (1.5) 143.1 (1.4) 143.5 (1.1) 142.8 (1.5)
BDI-II 1.8 (2.3) 9.9 (7.7) 8.5 (5.3) 8.8 (3.4) 9.5 (8.4)
Values represent means and standard deviations except Hoehn & Yahr values which are reported in median and range. MMSE - Mini-Mental
State Examination; DRS – Dementia Rating Scale; BDI-II - Beck Depression Inventory II; LPD – Left-side motor symptom onset; RPD –
Right-side motor symptom onset; T – Initial symptom tremor; NT – Initial symptom non-tremor ∗Same patients grouped by side of onset and
type of initial symptom.
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relations empirically identified three factors, including
general clock features, placement of numbers, and
placement of hands. An overall score is calculated by
summing all items.
The Ten Point Clock Test (TPCT) [42] was devel-
oped to provide a quick evaluation of clock drawings in
tertiary care settings, based on the placement of num-
bers and hands. The clock is divided into eighths and a
point is given for each non-anchor number drawn in the
appropriate segment. An additional point is awarded
for the accurate drawing of each hand, indicating the
time of 11:10. “10” represents a perfect drawing.
The Rouleau method [41] separately assesses the
drawing of the clock face, numbers and hands. The
face is scored according to the severity of distortion
on a 0–2 point scale with “2” indicating gross distor-
tion. Clock numbers are rated by severity of error in
spatial arrangement on a 0–4 point scale (“0” worst).
The hands are judged a 0–4 point scale (“0” worst) by
placement and length.
Two trained raters blind to clinical diagnosis (PD vs.
HC; and within the PD group, side and type of onset)
independently analyzed each drawing using each scor-
ing method.
Table 2
Clock drawing test scoring system (Rouleau et al. [41])
A. Integrity of the clock face (maximum: 2 points)
Score:
2 Present without gross distortion
1 Incomplete or some distortion (including size)
0 Absent or totally inappropriate
B. Presence and sequencing of the numbers (maximum: 4 points)
Score:
4 All present in the right order and at most minimal error in
the spatial arrangement
3 All present but errors in spatial arrangement
2 - Numbers missing or added but no gross distortions of the
remaining numbers
- Numbers placed in counterclockwise direction
- Numbers all present but gross distortion in spatial layout
(i.e. hemineglect, numbers outside the clock)
1 Missing or added numbers and gross spatial distortions
0 Absence or poor representation of numbers
C. Presence and placement of the hands (maximum: 4 points)
Score:
4 Hands are in correct position and the size difference is
respected
3 Slight errors in the placement of the hands or no
representation of size difference between hands
2 Major errors in the placement of the hands (significantly out
of course including 10 to 11)
1 Only one hand or poor representation of 2 hands
0 No hands or preservation on hands
RESULTS
Inter-rater reliability was determined by mean intra-
class coefficients (ICC) using a two-way random
effects model with absolute agreement. A high degree
of reliability was established for all four scoring sys-
tems: Sunderland (ICC = 0.97), CDIS (ICC = 0.85),
TPCT (ICC = 0.91) and Rouleau (ICC = 0.96).
Data from the two raters were averaged. Non-
parametric Kruskal-Wallis tests were conducted to
examine potential group effects. When indicated, the
Mann-Whitney test was used for follow-up analy-
ses and a more conservative alpha level of 0.01 was
adopted. No group differences emerged for the Sun-
derland, CDIS, or TPCT methods. Significant group
differences emerged using the Rouleau method.
Rouleau method
PD compared to HC. Mann-Whitney U tests were
performed to examine effects of group (alpha 0.05).
A significant effect of group was observed for the
numbers subscale (U = 144.5, p < 0.01), but not the
hands (U = 248.5, p = 0.69) or clock face (U = 224.0,
p = 0.272). The HC group performed better (M = 3.74,
SD = 0.56) than the PD group (M = 3.24, SD = 0.63).
The effect size was medium to large (r = −0.40).
Side of onset. Kruskal-Wallis tests were performed
to examine side of onset (alpha 0.05). A signifi-
cant effect of group was observed for the numbers
subscale (H (2) = 8.34, p < 0.02), but not the hands
(H (2) = 0.16, p = 0.92) or clock face (H (2) = 2.5,
p = 0.28). Post-hoc analyses (alpha 0.01) revealed a sig-
nificant difference on the numbers subscale between
the HC and LPD groups (U = 65.0, p < 0.005), with
HC performing better (HC M = 3.74, SD = 0.56; LPD
M = 3.16, SD = 0.65). The effect size was medium to
large (r = −0.49).
Type of initial symptom. A significant effect of group
was observed for the numbers subscale (H (2) = 8.75,
p < 0.02), but not hands (H (2) = 0.69, p = 0.71) or face
(H (2) = 1.46, p = 0.48). Post-hoc analyses (alpha 0.01)
revealed a significant difference on the numbers sub-
scale between the HC and non-tremor group (U = 63.5,
p < 0.004), with HC performing better (HC M = 3.74,
SD = 0.56; non-tremor M = −3.16, SD = 0.57) (Fig. 2).
The effect size was large (r = −0.50).
Interaction of side of onset and type of initial symp-
tom. Because of small sample sizes (LPD: 9 with, 7
without tremor; RPD: 6 with, 9 without tremor), the
following analyses should be considered preliminary.
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Fig. 1. Mean score for each of the three scales on the Rouleau scoring
system by side of onset. Error bars represent standard errors of the
mean. The LPD patients performed significantly more poorly than
HC, p < 0.01. The RPD patients did not differ from HC.
Fig. 2. Mean score for each of the three scales on the Rouleau scor-
ing system by type of initial symptom. Error bars represent standard
errors of the mean. The non-tremor onset patients performed signifi-
cantly more poorly than HC, p < 0.01. The tremor-onset patients did
not differ from HC.
A significant effect of group was observed for the num-
bers subscale (H (4) = 9.58, p < 0.05), but not hands
(H (4) = 1.70, p = 0.79) or face (H (4) = 2.70, p = 0.61).
Post-hoc analyses (using an alpha of 0.05 given the pre-
liminary nature of the data and small sample) revealed
significant group differences between the HC and LPD
non-tremor subgroup (U = 21.5, p < 0.006), HC and
LPD tremor subgroup (U = 43.5, p < 0.04), as well as
between HC and RPD non-tremor subgroup (U = 42.0,
p < 0.03. Medium to large effect sizes were observed
for HC and LPD non-tremor (r =−0.56), HC and
LPD tremor (r =−0.40), and HC and RPD non-tremor
(r = −0.42). A general pattern across the poorly per-
forming subgroups included a tendency to draw the
numbers on the right side of the clock too closely
Fig. 3. Mean score for the numbers subscale (Rouleau scoring sys-
tem) by side and type of initial symptom. Error bars represent
standard errors of the mean. The LPD and RPD non-tremor sub-
groups each performed significantly more poorly than HC, p < 0.05.
together, resulting in relatively larger gaps between
numbers on the left side of the clock (Fig. 3).
DISCUSSION
Our results revealed significant PD subgroup dif-
ferences in clock drawings by side and type of initial
motor symptom. Consistent with our hypotheses, LPD
(inferred right hemisphere dysfunction) and those
without tremor as the initial motor symptom per-
formed significantly worse than well-matched healthy
adults. These group differences were observed when
clocks were scored according to the Rouleau scor-
ing system [41], but were not observed with other
methods, reflecting the sensitivity of this system to spa-
tial arrangements among clock features. This finding
accords with those of Lee and colleagues [44] and Mat-
suoka and colleagues [45] in Alzheimer’s disease, who
reported that Rouleau scores correlated more strongly
than did other-system scores with right-parietal struc-
ture (i.e. grey matter volume) and function (i.e. cerebral
glucose metabolism). It also accords with the wider lit-
erature on visuospatial dysfunction in PD by subgroup
using measures that are generally not as common in
clinical use as is the CDT (e.g., 7, 9, 23, 35, 37).
Our examination of the relative sensitivity of scor-
ing methods on the CDT was motivated by the lack
of a single standard scoring system on this test that
is very widely used in PD and in other neurodegen-
erative and other neurological conditions. The fact
that the other CDT scoring systems were not sen-
sitive to group differences does not controvert our
finding with the Rouleau—rather, it provides informa-
tion, valuable in the clinic, that those other scoring
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systems should not be used if the aim is to under-
stand visuospatial function in PD, especially in regard
to subgroups.
Our findings suggest that the Rouleau system is
particularly sensitive to the type of errors seen in non-
demented patients with mild to moderate PD. Each of
the clock elements (face, numbers, and hands) is scored
by severity of errors ranging from mild to gross impair-
ment. By contrast, the other methods score the presence
or absence of errors typically seen in demented popu-
lations. For example, a clock feature may be absent or
a number drawn more than 45 degrees off course. In
our high-functioning sample, these types of errors were
rare, resulting in ceiling performance on these scales.
The PD-related effects using the Rouleau method were
exclusive to the numbers subscale, which emphasizes
errors in spatial arrangement of numbers, suggesting
that overall drawing difficulties did not explain the
findings.
Appreciation of the spatial relations among objects
relies on the dorsal visual stream extending from the
striate cortex to the parietal lobes [46]. The CDT
has long been used as a measure of visuospatial and
parietal-lobe functioning [74, 48], and the role of the
right parietal lobe has often been emphasized because
of its relevance to unilateral spatial neglect [49]. Of
particular importance to the present study, Tranel and
colleagues [50] observed that patients with right basal
ganglia lesions (without PD) showed problems with
spatial organization and number placement on the
CDT, but not other type of errors, including hand place-
ment. These findings are remarkably consistent with
those of the present study, in which LPD (greater right
basal ganglia dysfunction) showed impairments in
aligning the numbers, but did not show difficulties with
hand setting. These visuospatial deficits were observed
in LPD but not RPD, suggesting relatively selective
disruption of right-hemisphere circuits including the
midbrain, basal ganglia, and parietal lobe.
When analyzing clock drawings by type of initial
symptom, we found that the subgroup without tremor
had more problems aligning numbers than did control
participants. Group differences were not observed for
the clock face or hands, indicating that general draw-
ing difficulties did not explain the findings. Relative
to tremor-dominant PD, non-tremor dominant PD is
associated with greater DA loss in the midbrain even
when there are similar motor severity scores [28]. In
those who present with non-tremor symptoms but not
with tremor, clinical symptom severity correlates with
severity of the DA deficiency in the striatum and with
disease progression [36]. In light of the known relation
between right parietal-lobe functioning and CDT per-
formance, the specific visuospatial problems observed
in non-tremor PD patients likely reflect greater DA
loss interacting with the dysfunction of the right-
hemisphere cortico-striato-thalamic circuit, as inferred
by side of onset.
Limitations of the present study include the use
of a single measure, the CDT, to investigate visu-
ospatial cognition by PD subtype, as well as the
relatively small sample size. While investigating per-
formance by PD subtype on this measure alone was
justified by previous research, subtype analysis should
be conducted to examine cognition across multiple
domains (e.g., visuospatial function, learning, mem-
ory, executive function; see [51] for a recent example
of investigation of the latter). To minimize the effect
of sample size, we used non-parametric analyses and
a conservative alpha for post-hoc analyses and found
medium to large effect sizes.
In sum, clinical characteristics at PD onset provide a
method of observing how disruption of select dopamin-
ergic circuits influences cognition in non-demented
patients. This study examined the relation between
visuospatial cognition and side and type of initial motor
symptom. As expected, patients with motor symptoms
starting on the left side of the body, as well as non-
tremor patients, performed more poorly than healthy
control participants. These deficits likely stem from
substantial DA loss within the right midbrain and basal
ganglia, which may disrupt connections to the right
parietal lobe. The findings highlight the importance
of considering subtypes when examining cognition in
PD.
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